Correlation Between Sana Biotechnology and Viracta Therapeutics
Can any of the company-specific risk be diversified away by investing in both Sana Biotechnology and Viracta Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sana Biotechnology and Viracta Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sana Biotechnology and Viracta Therapeutics, you can compare the effects of market volatilities on Sana Biotechnology and Viracta Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sana Biotechnology with a short position of Viracta Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sana Biotechnology and Viracta Therapeutics.
Diversification Opportunities for Sana Biotechnology and Viracta Therapeutics
0.69 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Sana and Viracta is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Sana Biotechnology and Viracta Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viracta Therapeutics and Sana Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sana Biotechnology are associated (or correlated) with Viracta Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viracta Therapeutics has no effect on the direction of Sana Biotechnology i.e., Sana Biotechnology and Viracta Therapeutics go up and down completely randomly.
Pair Corralation between Sana Biotechnology and Viracta Therapeutics
Given the investment horizon of 90 days Sana Biotechnology is expected to under-perform the Viracta Therapeutics. In addition to that, Sana Biotechnology is 1.11 times more volatile than Viracta Therapeutics. It trades about -0.22 of its total potential returns per unit of risk. Viracta Therapeutics is currently generating about 0.01 per unit of volatility. If you would invest 22.00 in Viracta Therapeutics on September 23, 2024 and sell it today you would lose (1.00) from holding Viracta Therapeutics or give up 4.55% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Sana Biotechnology vs. Viracta Therapeutics
Performance |
Timeline |
Sana Biotechnology |
Viracta Therapeutics |
Sana Biotechnology and Viracta Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Sana Biotechnology and Viracta Therapeutics
The main advantage of trading using opposite Sana Biotechnology and Viracta Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sana Biotechnology position performs unexpectedly, Viracta Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viracta Therapeutics will offset losses from the drop in Viracta Therapeutics' long position.Sana Biotechnology vs. Olema Pharmaceuticals | Sana Biotechnology vs. Cullinan Oncology LLC | Sana Biotechnology vs. Zentalis Pharmaceuticals Llc | Sana Biotechnology vs. X4 Pharmaceuticals |
Viracta Therapeutics vs. Fate Therapeutics | Viracta Therapeutics vs. Sana Biotechnology | Viracta Therapeutics vs. Caribou Biosciences | Viracta Therapeutics vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
CEOs Directory Screen CEOs from public companies around the world | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |